Average Co-Inventor Count = 4.75
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. N.v. Innogenetics S.a. (7 from 43 patents)
2. Janssen Biotech, Inc. (4 from 410 patents)
3. Janssen Pharmaceutica Nv (3 from 2,078 patents)
4. Innogenetics N.v. (2 from 82 patents)
16 patents:
1. 11673943 - Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof
2. 10851156 - Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies
3. 10519223 - Antibodies to pyroglutamate amyloid-β and uses thereof
4. 10196440 - Anti-PHG-tau antibodies and their uses
5. 10000559 - Anti-PHF-tau antibodies and their uses
6. 9745371 - Anti-PHF-tau antibodies and their uses
7. 9371376 - Anti-PHF-tau antibodies and their uses
8. 8163873 - Isolated microtubule-associated protein tau peptides and kit
9. 6900293 - Monoclonal antibodies directed against the microtubule-associated protein tau
10. 6500674 - Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
11. 6238892 - Monoclonal antibodies directed against the microtubule-associated protein tau
12. 6232437 - Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.
13. 6010913 - Isolated human tau peptide
14. 6008024 - Monoclonal antibodies specific for PHF-tau, hybridomas secreting them,
15. 5861257 - Monoclonal antibodies directed against the microtubule-associated